1-14 of 14
Ming Yin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Daratumumab Combinations in US Veterans: Patient Characteristics and Outcomes

Sonika Prasad, Ming Yin, Julie A Lynch, Cecelia J Madison, Daphne R Friedman, Martin William Schoen
Journal: Blood
Blood (2023) 142 (Supplement 1): 6705.
https://doi.org/10.1182/blood-2023-190652
Published: 2023
Journal Articles

Pirtobrutinib, A Next Generation, Highly Selective, Non-Covalent BTK Inhibitor in Previously Treated Mantle Cell Lymphoma: Updated Results from the Phase 1/2 BRUIN Study

Michael Wang, Nirav N. Shah, Alvaro J. Alencar, James N. Gerson, Manish R. Patel, Bita Fakhri, Wojciech Jurczak, Xuan Ni Tan, Katharine Lewis, Timothy S. Fenske, Catherine C. Coombs, Ian W. Flinn, David John Lewis, Steven Le Gouill, M. Lia Palomba, Jennifer A. Woyach, John M. Pagel, Nicole Lamanna, Jonathon B. Cohen, Minal A. Barve, Paolo Ghia, Toby A. Eyre, Pier Luigi Luigi Zinzani, Chaitra S. Ujjani, Youngil Koh, Koji Izutsu, Ewa Lech-Marańda, Constantine S. Tam, Suchitra Sundaram, Ming Yin, Binoj Nair, Minna Balbas, Donald Tsai, Anthony R. Mato, Chan Yoon Cheah
Journal: Blood
Blood (2021) 138 (Supplement 1): 381.
https://doi.org/10.1182/blood-2021-149138
Published: 2021
Journal Articles

BRUIN MCL-321: A Phase 3 Open-Label, Randomized Study of Pirtobrutinib Versus Investigator Choice of BTK Inhibitor in Patients with Previously Treated, BTK Inhibitor Naïve Mantle Cell Lymphoma (Trial in Progress)

Toby A. Eyre, Nirav N. Shah, Steven Le Gouill, Martin H. Dreyling, Elisabeth Vandenberghe, Wojciech Jurczak, Yucai Wang, Chan Yoon Cheah, Mitul D. Gandhi, Christopher H. Chay, Jeff P. Sharman, David Jacob Andorsky, Ming Yin, Minna Balbas, Jennifer Kherani, Michael L. Wang
Journal: Blood
Blood (2021) 138 (Supplement 1): 2422.
https://doi.org/10.1182/blood-2021-145920
Published: 2021
Journal Articles

LOXO-305, A Next Generation, Highly Selective, Non-Covalent BTK Inhibitor in Previously Treated Mantle Cell Lymphoma, Waldenström's Macroglobulinemia, and Other Non-Hodgkin Lymphomas: Results from the Phase 1/2 BRUIN Study

Michael Wang, MD, Nirav N. Shah, MD, Alvaro J. Alencar, MD, James N. Gerson, MD, Manish R. Patel, MD, Bita Fakhri, MDMPH, Wojciech Jurczak, MD PhD, Xuan Ni Tan, MD, Katharine L Lewis, MBBS, Timothy S. Fenske, MD, Catherine C. Coombs, MD, Ian W. Flinn, MD PhD, David John Lewis, MD, Steven Le Gouill, MD PhD, M. Lia Palomba, MD, Jennifer A. Woyach, MD, John M. Pagel, MDPhD, Nicole Lamanna, MD, Jonathon B. Cohen, MDMS, Minal Barve, MD, Paolo Ghia, MD PhD, Toby A. Eyre, Ming Yin, Binoj Nair, PhD, Donald Tsai, MD PhD, Nora C. Ku, MD, Anthony Mato, MD, Chan Yoon Cheah, MBBS
Journal: Blood
Blood (2020) 136 (Supplement 1): 8–10.
https://doi.org/10.1182/blood-2020-134314
Published: 2020
Journal Articles

Concurrent Treatment of VEGFR Tyrosine Kinase Inhibitors (TKIs) and Factor Xa Inhibitors Is Associated with Increased Bleeding Risks

Sandip Patel, MBBS, Tiffany George, MD, Tzu-Fei Wang, MD MPH, Sherry Mori Vogt, Pharm D, Edmund Folefac, MD, Ming Yin, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3681.
https://doi.org/10.1182/blood-2019-130465
Published: 2019
Journal Articles

Long-Term Follow-up of Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell Lymphoma

Michael Wang, MD, Simon Rule, MD, Pier Luigi Zinzani, MD, Andre Goy, MD, Olivier Casasnovas, MD, Stephen D. Smith, MD, Gandhi Damaj, MD PhD, Jeanette K. Doorduijn, MD PhD, Thierry Lamy, Franck Morschhauser, MD, Carlos Panizo, MD PhD, Bijal D. Shah, MD, Andrew Davies, Richard Eek, MBCHB, Jehan Dupuis, MD, Eric Jacobsen, MD, Arnon P. Kater, MD PhD, Steven LE Gouill, MD PhD, Lucie Oberic, MD, Tadeusz Robak, MD PhD, Richa Dua, PharmD, Melanie M. Frigault, PhD, Raquel Izumi, PhD, Dorothy Nguyen, MD PhD, Priti Patel, MD, Ming Yin, PhD, Wojciech Jurczak, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2876.
https://doi.org/10.1182/blood-2018-99-110327
Published: 2018
Journal Articles

Exposure-Response of the Bruton Tyrosine Kinase Inhibitor, Acalabrutinib, in the Treatment of Hematologic Malignancies

Feng Jin, PhD, Ming Yin, PhD, Vinay Mandava, Helena Edlund, PhD, Marilee Andrew, PhD, Priti Patel, MD, Eric Masson, PharmD, Nidal Al-Huniti, PhD, Xiaolin Wang, ScD, J. Greg Slatter, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1268.
https://doi.org/10.1182/blood.V130.Suppl_1.1268.1268
Published: 2017
Journal Articles

Effect of Transfusion of the Third Party Umbilical Cord Blood on Haplo-Identical Hematopoietic Stem Cell Transplantation

Jing Bo Wang, PhD, Xin Hong Fei, Hao Yu Cheng, Yu Ming Yin, Wei Jie Zhang, Shu Qin Zhang, Qian Li, Song Xue, Jiang Ying Gu, Jun Bao He, Fan Yang, Meng Qi Liu, Jie Zhao, Dai-Hong Liu
Journal: Blood
Blood (2015) 126 (23): 1943.
https://doi.org/10.1182/blood.V126.23.1943.1943
Published: 2015
Journal Articles

Allogeneic Halpo-Identical Hematopoietic Stem Cell Transplantation for High-Risk Leukemia

Jing Bo Wang, PhD, Xin Hong Fei, Yu Ming Yin, Hao Yu Cheng, Wei Jie Zhang, Jiang Ying Gu, Song Xue, Qian Li, Fan Yang, Shu Qin Zhang, Jun Bao He, Meng Qi Liu, Jie Zhao, Dai-Hong Liu
Journal: Blood
Blood (2015) 126 (23): 5514.
https://doi.org/10.1182/blood.V126.23.5514.5514
Published: 2015
Journal Articles

Retinoic acid enhances the generation of hematopoietic progenitors from human embryonic stem cell–derived hemato-vascular precursors

Chen Yu, Yanxia Liu, Zhenchuan Miao, Ming Yin, Wei Lu, Yaxin Lv, Mingxiao Ding, Hongkui Deng
Journal: Blood
Blood (2010) 116 (23): 4786–4794.
https://doi.org/10.1182/blood-2010-01-263335
Published: 2010
Includes: Supplemental data
Journal Articles

Haploidentical Hematopoietic Stem Cell Transplantation of Sex-Matched Donor-Recipient Pair Has Survival Advantage: A Single-Center Study of 440 Cases

Tong Wu, MD, Yan-Li Zhao, MD, Jing-Bo Wang, MD, Xing-Yu Cao, MD, Yu-Ming Yin, MD, Yuan Sun, MD, Yue Lu, MD, Jia-Rui Zhou, MD, Yan-Qun Gao, MD, Wan-Ming Da, MD, Shu-Quan Ji, MD, Yao-Chen Zhang, MD, Dao-Pei Lu, MD
Journal: Blood
Blood (2010) 116 (21): 228.
https://doi.org/10.1182/blood.V116.21.228.228
Published: 2010
Journal Articles

Successful Rescue of Refractory/Recurrent Myelogenous Leukemia by Allogeneic Hematopoietic Cell Transplantation and Prophylactic Immunotherapy.

Jing-Bo Wang, Tong Wu, Wan-Ming Da, Chun-Rong Tong, Xing-Yu Cao, Zhi-Yong Gao, Lujia Dong, Yan-Li Zhao, Yu-Ming Yin, Yuan Sun, Yue Lu, Shu-Quan Ji, Dao-Pei Lu
Journal: Blood
Blood (2009) 114 (22): 4095.
https://doi.org/10.1182/blood.V114.22.4095.4095
Published: 2009
Journal Articles

Significantly Reduce Acute Graft-Versus-Host Disease in Haploidentical Stem Cell Transplantation by Using Cord Blood as the Third Party Cells.

Dao-Pei Lu, Tong Wu, Zhi-Yong Gao, Jing-Bo Wang, Xing-Yu Cao, Yan-Li Zhao, Lujia Dong, Yu-Ming Yin, Shu-Quan Ji, Wan-Ming Da
Journal: Blood
Blood (2008) 112 (11): 2211.
https://doi.org/10.1182/blood.V112.11.2211.2211
Published: 2008
Journal Articles

Management of Early Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation by Donor’s Dendritic Cell-Primed Cytokine- Induced Killer Cells

Jing-Bo Wang, Tong Wu, Jun-Fang Yang, Jian-Ping Zhang, Xing-Yu Cao, Yu-Ming Yin, Yuan Sun, Rong-Mu Luo, Dao-Pei Lu, Chun-Rong Tong
Journal: Blood
Blood (2008) 112 (11): 829.
https://doi.org/10.1182/blood.V112.11.829.829
Published: 2008